Carlo Dufour Selected Research

Shwachman-Diamond Syndrome

9/2020	Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).
1/2020	Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).
1/2016	Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlo Dufour Research Topics

Disease

40	Aplastic Anemia (Anemia, Hypoplastic) 06/2022 - 09/2003
16	Fanconi Anemia (Fanconi's Anemia) 01/2021 - 05/2002
10	Neoplasms (Cancer) 01/2020 - 06/2005
8	Neutropenia 11/2020 - 06/2008
8	Infections 01/2020 - 04/2002
7	Bone Marrow Failure Disorders 10/2021 - 09/2003
7	Leukemia 01/2020 - 12/2002
5	idiopathic Aplastic anemia 01/2022 - 08/2005
5	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2021 - 04/2009
4	Anemia 01/2022 - 02/2010
4	Cytopenia 11/2021 - 10/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 03/2012
4	Autosomal Recessive 3 Severe Congenital Neutropenia 01/2019 - 03/2010
3	Autoimmune Lymphoproliferative Syndrome 01/2022 - 11/2016
3	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2021 - 09/2009
3	Hemorrhage 01/2021 - 10/2010
3	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020 - 11/2017
3	Shwachman-Diamond Syndrome 09/2020 - 01/2016
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 11/2016
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 12/2013
3	Bronchiolitis Obliterans Syndrome 11/2019 - 12/2013
3	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 10/2018 - 03/2009
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2003 - 04/2002
2	Pancytopenia 06/2022 - 09/2007
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2021 - 04/2013
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 12/2019
2	Philadelphia Chromosome 01/2021 - 12/2019
2	Evans Syndrome 01/2020 - 11/2016
2	Lymphoma (Lymphomas) 01/2019 - 12/2003
2	Hypersensitivity (Allergy) 09/2015 - 10/2013
1	Hepatitis 06/2022
1	Arthralgia (Joint Pain) 01/2022
1	Splenomegaly 01/2022
1	Cartilage-hair hypoplasia 01/2022
1	Arthritis (Polyarthritis) 11/2021
1	Congenital Bone Marrow Failure Syndromes 10/2021
1	Headache (Headaches) 01/2021
1	Fever (Fevers) 01/2021
1	Lymphopenia (Lymphocytopenia) 11/2020
1	Leukopenia 11/2020
1	Common Variable Immunodeficiency 11/2020
1	Protein Deficiency 11/2020
1	Viremia 10/2020
1	Virus Diseases (Viral Diseases) 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2020
1	Osteonecrosis (Kienbock's Disease) 01/2020
1	COVID-19 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 06/2015 - 09/2007
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 09/2004
6	Sirolimus (Rapamycin)FDA Link 01/2022 - 04/2014
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 09/2004
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 09/2004
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2021 - 10/2015
4	Pharmaceutical PreparationsIBA 06/2019 - 09/2012
4	Biological ProductsIBA 01/2016 - 06/2005
3	SteroidsIBA 11/2021 - 04/2009
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 09/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009 - 09/2003
2	eltrombopag FDA Link 01/2022 - 06/2019
2	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 12/2019
2	nilotinib FDA Link 01/2021 - 12/2019
2	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 12/2003
2	Inosine Triphosphate (ITP)IBA 01/2020 - 11/2016
2	Thrombopoietin (c-mpl Ligand)IBA 10/2019 - 09/2007
2	AntibodiesIBA 01/2019 - 02/2015
2	thymoglobulin FDA Link 01/2018 - 06/2012
2	fludarabineIBA 09/2017 - 12/2013
2	pegfilgrastim (Neulasta)FDA Link 10/2016 - 03/2010
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 01/2013
2	AntigensIBA 02/2015 - 01/2013
2	HepcidinsIBA 04/2013 - 05/2010
2	Ribosomal Proteins (Ribosomal Protein)IBA 02/2010 - 09/2009
2	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2005 - 05/2003
2	Interferon-gamma (Interferon, gamma)IBA 09/2004 - 09/2003
1	Transaminases (Aminotransferases)IBA 06/2022
1	2,6-dinitrotoluene (DNT)IBA 01/2022
1	Abatacept (Orencia)FDA Link 11/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021
1	BilirubinIBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	TransferasesIBA 01/2021
1	diepoxybutaneIBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	LipopolysaccharidesIBA 11/2020

Therapy/Procedure

21	Transplantation 02/2022 - 12/2013
20	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2009
13	Therapeutics 01/2022 - 12/2003
12	Stem Cell Transplantation 10/2021 - 02/2010
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 01/2016
3	Cell Transplantation 01/2021 - 01/2018
3	Drug Therapy (Chemotherapy) 04/2008 - 12/2002
2	Aftercare (After-Treatment) 09/2014 - 04/2013
1	Treatment Delay 01/2022
1	Haploidentical Transplantation 01/2020
1	Radiotherapy 01/2020